Facinicline
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2009 (NCT00884507)
Timeline
Indications
Mechanism of action
CHRNA7 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
O=C(N[C@@H]1CN2CCC1CC2)c1n[nH]c2ccccc12- Mol. weight
- 270.34 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2151439 ↗
Also known as
- ro5313534
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01196065 | Phase 1 | Sep 1, 2010 | Roche |
| NCT00884507 | Phase 2 | May 1, 2009 | Roche |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 2 | 2 | 2 | 2009 |
1 organizations
Page 1 / 1